PROVIDER PROFILE · NPI 1629161245

Quita CrucigerM.D.

DermatologySan Francisco, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,659

Unique beneficiaries

—

Total services

4,463

Distinct HCPCS

Medicare payment

$160K

Peer benchmark

Total Medicare services vs. 1,546 Dermatology providers in CA — above median (cohort median 2,504).

PRESCRIBING · PART D · 2024

Total Rx claims

244

Beneficiaries

—

Total drug cost

$5K

Distinct drugs

Brand share

5.3%

Top prescribed drugs

Triamcinolone Acetonide63 claims

Acyclovir54 claims

Clobetasol Propionate30 claims

Metronidazole26 claims

Mupirocin24 claims

QUALITY · MIPS · 2024

Final MIPS score

0.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

-9.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Quita Cruciger's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Ucsf Dermatopathology Service Clinical Laboratory · San Francisco, CA	90	133
Arlene Hoffman Podiatry · San Francisco, CA	17	29
Kevin Denny Ophthalmology · San Francisco, CA	14	19
Marc Cruciger Ophthalmology · San Francisco, CA	13	15
MARIN GENERAL HOSPITAL	12	25

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history